Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system ...
Nov 23, 2022
0
64
Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small ...
Nov 23, 2022
0
913
In a step likely to advance personalized cancer treatment, scientists have—for the first time—shown in patients that levels of biomarkers are not enough to tell which patients are likely to respond best to immunotherapy.
Nov 22, 2022
0
69
A promising new study released by the University of Colorado Cancer Center suggests that recurrence of certain cancers can be significantly decreased by irradiating only a select set of lymph nodes near a tumor rather than ...
Nov 16, 2022
0
78
Two new studies from researchers at Fred Hutchinson Cancer Center in Seattle reveal how bacteria infiltrate tumors and could be helping tumors progress and spread. The research team also showed that the different microbial ...
Nov 16, 2022
0
57
Patients with head and neck cancer who have more genetic material on chromosome 9 in their cancer cells survive three times longer after receiving immunotherapy than those with less genetic material there, a new study finds. ...
Nov 14, 2022
0
591
Personalized care has been a buzzword in medicine for years, but new research on cancer treatment is taking it to a new level.
Nov 13, 2022
0
33
For the first time, scientists have used CRISPR technology to insert genes that allow immune cells to focus their attack on cancer cells, potentially leaving normal cells unharmed and increasing the effectiveness of immunotherapy. ...
Nov 10, 2022
0
68
New technology can trace which populations of breast cancer cells are responsible for the spread of the disease, and for the first time highlights how the location of cancer cells could be as important as mutations in tumor ...
Nov 9, 2022
0
33
People are already calling it the Machete Paper.
Nov 8, 2022
0
53
